• Journal of Nutrition and Health
• /
• 제31권8호
• /
• pp.1315-1323
• /
• 1998

Effect of oral taurine supplementation on plasma total and phospholidpid -fatty acid profiles and their metabolism were evaluated in healthy female adults. Among twenty five female volunteers(23.6$\pm$0.3 years old ) participated in the taruine supplementation program(6g taurine /day), twenty four subjects succesfully completed the 2 week program , and only nine subjects continued to take taurine for another 2 weeks. Levels of plasma fatty acids and taruine were measured by gas-liquid chromatobraphy and an automated amino acid analyzer based on ion exchange chromatography, respectively. Plasma taurine concentration s of the subjects were 108. 7$\pm$3.4 , 184.2$\pm$8.2 and 235.9$\pm$77.0$\mu$emol/L at 0 , 2 and 4 weeks of taurine supplementation. Fatty acid compositions and elongation and desaturation indices of polyunsaturated fatty acids (PUFA) in plasma total lipids were not influenced by oral taurine supplementation. However, fatty acid compositions and their metabolism in plasma phospholipids were significantly affected by taurine supplementation in female adults. Compared to the values for 0 week, the percentage of saturated fatty acids (SFA) in plasma phospholipid was significantly lowered at 2 weeks, but elevated at 4 weeks of taurine supplementation. In contrast , the percentage of phospholipid PUFA significantly increased at 2 weeks and decreased at 4 weeks of taurine supplementation from to the values for 0 weeks. Foru weeks of oral taurine supplementation signifinatly elevated the eongation index(20 : 4$\omega$6 ⇒22 : 4 $\omega$6, p<0.01), and decreased the desaturation index (20 : 3 $\omega$6 ⇒20 : 4 $\omega$6 , p<0.01) of $\omega$6 fatty acids in plasma phospholipids. Plasma taurine concentration was positively correlated with the percentage of 14 : 0 fatty acids and the enlongation index o f$\omega$3 fatty acids(20 : 5 $\omega$3 ⇒22 : 5 $\omega$3), and thenegatively correlated with the percentage of 20 : 0 in plasma phospholipids. These results indicate that oral taurine supplementation for 4 weeks signidicantly elelvated the percentage of SFA, and lowered the percentage of PUFA in plasma phospholipids with no influence on plasm total fatty aicd composition in healthy female adults.

• 한국가금학회:학술대회논문집
• /
• 한국가금학회 2004년도 제21차 정기총회 및 학술발표회
• /
• pp.93-94
• /
• 2004

The experiments was conducted to investigate the effects of dietary supplementation of feather meal and pyridoxine on the taurine content of egg yolk and performance of laying hens. Feeding trial was conducted with 900 31-wk-old Hy-Line Brown layers for 4wks. The experiment consisted of six dietary treatments: control(basal diet), feather meal(FM) 3 % diet(FM 3 %), FM 3 % + pyridoxine supplemented diet(FM 3 % + Pyridox), FM 6 % diet, FM 6 % + pyridoxine supplemented diet(FM 6% + Pyridox), Synthetic taurine 0.25 % supplemented diet(Taurine). Egg production of birds fed FM 3% was highest and those of the FM diets were also higher than those of Taurine and the control. Egg weight of Taurine was significantly lower than those of FM 3 %, FM 6 % and the control but were not significantly different from those of FM 3 % + Pyridox or FM 6 % + Pyridox. Feed intake of the control was greater than those of FM 6 %, FM 6% + Pyridox or Taurine treatment but was not significantly different from those of FM 3 % and FM 3 % + Pyridox. Feed conversion of the control was significantly higher than other treatments in which that of FM 6 % was lowest. Broken and soft egg production of Taurine was highest while that of the control was lowest among treatments. Taurine content of egg yolk significantly increased by supplementation of taurine(64.7 %). FM 6 % + pyridoxine(57 %), FM 3% + pyridoxine (32.1%) and FM 6% (16.6 %). Sensory evaluation data of Taurine has shown the highest score in most of sensory attributes. It is concluded that taurine can be enriched in egg yolk by supplementation of 6 % FM diet and pyridoxine as well as 0.25 % synthetic taurine.

• 한국식품영양과학회지
• /
• 제30권2호
• /
• pp.314-319
• /
• 2001

In the present study, effects of $\beta$-alanine, a known taurine antagonist for its structural similarity, on the adaptive regulation and kinetic behavior of the taurine transporter were investigated in the HT-29, human colon carcinoma cell line. Pretreatment of the cell with $\beta$-alanine(10mM) for varying periods from 3 to 30 hrs significantly reduced the taurine uptake compared to the value for control cells. This decrease in the taurine transporter activity was dependent on the incubation time with $\beta$-alanine, and the maximal down-regulation of the transporter activity was observed in cells pretreated with $\beta$-alanine for 24 hrs (25% of the control value, p<0.01). The taurine transporter appears to bind exclusively with $\beta$-alanine in the HT-29 cells since the same concentration of $\alpha$-alanine added in the culture medium for 24 hrs did not influence the taurine uptake. Kinetic analyses of the taurine transporter activity was performed in the HT-29 cell line with varying taurine concentration (5~60$\mu$M) in the uptake medium. Active taurine uptake was significantly lower in $\beta$-alanine pretreated cells compared to the value for control cells in the range of taurine concentration used in the experiment (p<0.001). The cells pretreated with $\beta$-alanine showed a 50% lower maximal velocity (Vmax, 1.7$\pm$2.0 nmole.mg $protein^{-1}$.$30min^{-1}$), and a 99% higher Michaelis constant (Km, 40.3$\pm$7.6$\mu$M) than the control values (3.3$\pm$1.9 nmole.mg $protein^{-1}$.$30min^{-1}$, and 20.3$\pm$2.1$\mu$M, respectively). These results on kinetic data suggest that $\beta$-alanine induced down-regulation of the taurine transporter activity was associated with decreases in both maximal velocity and affinity of the transporter.

• Biomolecules & Therapeutics
• /
• 제8권2호
• /
• pp.194-198
• /
• 2000

Taurine, 2-aminoethanesulfonic acid is widely distributed in animal tissues and has a variety of bio-logical activities. A recent worldwide study demonstrated beneficial effects of taurine on aging and age-associated disorders. In general, taurine levels in the brain decease when an animal is subjected to pathologic conditions such as ischemia-anoxia and seizure. But the taurine levles tend to increase in the brain in hypertensive state. In the present study, the blood-brain barrier (BBB) transport of [$^3$H]taurine was compared between spontaneously hypertensive rats (SHR) and normotensive Sprague-Dawley rats (SD) using intravenous injection technique in vivo. We also obtained pharmacokinetic parameters of plasma volume maker, [$^{14}$ C] sucrose and [$^3$H]taurine after inject to rats simulatenously. BBB permeability surface area product (PS) value of [$^3$H]taurine in SHR (16$\pm$2.9$\times$10$^{-3}$ ml/min/g) was significantly higher than that in SD (7.4$\pm$0.8$\times$10$^{-3}$ ml/min/g). There is also significant difference for brain uptake of [$^3$H]taurine between SHR (0.195$\pm$0.031%ID/g) and SD (0.058$\pm$0.003% ID/g). This is due to difference of area under the plasma concentration-time curve (AUC) and that of total clearance (Class) between SHR and SD. No significant difference was indicated from other organ uptakes such as lung, heart, liver SHR and SD. But also kidney uptake was much higher in SHR. In conclusion, [$^3$H]taurine in plasma was slowly eliminated in SHR than in SD and uptake of [$^3$H]taurine in SHR is much higher than that of SD. This results suggest increased taurine level in the brain in hypertension state have an any effect on the brain uptake of taurine.

• Biomolecules & Therapeutics
• /
• 제17권2호
• /
• pp.175-180
• /
• 2009

Taurine is the most abundant free amino acid in the retina and transported into retina via taurine transporter (TauT) at the inner blood-retinal barrier (iBRB). In the present study, we investigated whether the taurine transport at the iBRB is regulated by oxidative stress or disease-like state in a conditionally immortalized rat retinal capillary endothelial cell line (TR-iBRB) used as an in vitro model of iBRB. First, [$^3H$]taurine uptake and efflux by TR-iBRB were regulated in the presence of extracellular $Ca^{2+}$. [$^3H$]Taurine uptake was inhibited and efflux was enhanced under $Ca^{2+}$ free condition in the cells. In addition, oxidative stress inducing agents such as tumor necrosis factor-$\alpha$ (TNF-$\alpha$), lipopolysaccharide (LPS), diethyl maleate (DEM) and glutamate increased [$^3H$]taurine uptake and decreased [$^3H$]taurine efflux in TR-iBRB cells. Whereas, 3-morpholinosydnonimine (SIN-1), which is known to NO donor decreased [$^3H$]taurine uptake. Lastly, TR-iBRB cells exposed to high glucose (25 mM) medium and the [$^3H$]taurine uptake was reduced about 20% at the condition. Also, [$^3H$]taurine uptake was decreased by cytochalasin B, which is known to glucose transport inhibitor. In conclusion, taurine transport in TR-iBRB cells is regulated diversely at extracellular $Ca^{2+}$, oxidative stress and hyperglycemic condition. It suggested that taurine would play a role as a retinal protector in diverse disease states.

• 대한약리학회지
• /
• 제28권1호
• /
• pp.27-40
• /
• 1992

Taurine은 유황 함유 아미노산으로서 뇌내에서 억제작용을 갖는 신경전달물질 역할을 하는것으로 알려져 있다. Taurine을 가토의 측뇌실내에 투여하여 혈압 및 심박에 미치는 영향을 검토하고 그 작용 기전을 규명코자 본 연구를 시행하여 얻은 연구결과는 다음과 같다. Taurine $(0.15{\sim}1.5\;mg)$은 urethane 마취 가토의 측뇌실내로 주사하였을때 혈압강하작용 및 심박감소작용이 현저하고 지속적인 용량반응 곡선을 나타내었다. 이와 동시에 상당한 호흡억제 작용도 관찰되었다. 그러나 동일량의 taurine을 정맥내에 투여시 혈압 및 심박에 아무런 영향을 미치지 못하였다. Taurine의 혈압 하강작용은 chlorisondamine, clonidine, strychnine, bicuculline등으로 전처치시 유의하게 억제되었으나 atropine, 양측 미주신경절단, propranolol 및 metoclopramide등의 전처치로 영향을 받지 않았다. 더우기 taurine은 norepinephrine의 승압 반응에도 영향을 미치지 못하였다. Taurine의 심박감소 작용은 chlorisondamine, propranolol, clonidine, strychnine 및 bicuculline등으로 전처리시 현저히 차단되었으나 atropine, 양측 미주신경절단, metoclopramide 등의 전처리로 영향을 받지 않았다. 이상의 연구한 결과로 보아, taurine은 가토의 측뇌실내 투여시 지속적이며 현저한 혈압하강 및 심박감소를 일으키며 이러한 작용은 뇌내의 catecholamine 뉴론과 관련있는 taurine (glycine) 및 gamma-aminobutyric acid (GABA) 수용체를 통해서 나타나는 것으로 사료된다.

• Journal of Animal Science and Technology
• /
• 제46권5호
• /
• pp.753-762
• /
• 2004

우모분(FM)과 우모분 digests가 육계의 성장률과 계육(가슴살, 다릿살) 및 심장의 taurine함량에 미치는 영향을 조사하기 위해 갓 부화한 Ross${\circledR}$ 병아리 100수를 5처리 2반복 반복당 10수씩(암 수 5수씩) 배치하여 6주간 사양시험을 실시하였다. 시험사료는 기초사료(control) 에 FM 5% 첨가사료(FM), NaOH 처리 FM 5% 첨가사료(NaOH-FM), $HNO_3$ 처리 FM5% 첨가사료$(HNO_3$-FM) 그리고 합성 타우린0.5% 첨가사료(Taurine)를 시험사료로 공시하여 42일간 실시하였으며 21일령까지는 대조구사료를 모두에게 급여하였고, 처리 사료는 22일령부터 42일령까지 급여하였다. 증체량에 있어 처리구들은 control에 비해 낮았지만 유의차가 없었다. 사료 섭취량은 Taurine과 FM 급여구가 대조구에 비해 낮았고 NaOH-FM과 $HNO_3$-FM구들이 FM구 보다는 높은 경향이 있었다. 사료요구율은 NaOH-FM구가 FM과 $HNO_3$-FM구 보다 유의하게 높았고 대조구와 Taurine구와는 유의한 차이가 없었다. 대조구의 taurine 함량을 보면 심장근육이 1482$\mu$g/g 으로 가장 높았고 다리근육이 778$\mu$g/g이었고 가슴살이 79$\mu$g/g으로 낮았다. 다리살과 가슴살의 경우 처리간에 유의차(P<0.01)가 있었으나 심장에서는 유의차가 없었다. 다리살의 경우 control에 비해 처리구들의 taurine 함량이 유의하게 높았는데 Taurine 첨가구에서는 170%, FM구는 123%, NaOH-FM구는 122% 그리고$HNO_3$-FM구는 63% 높았다. 가슴 근육의 타우린 함량은 Taurine구가 타처리구들에 비해 유의하게 높았고 대조구에 비해서는 246% 높았다 성장의 경우에는 처리구들간에 차이가 없었다. 결론적으로 육계후기 사료에 우모분을 5% 첨가했을 때, 다리근육의 타우린 함량은 효과적으로 강화시킬수 있었으며 우모분을 NaOH 나 $HNO_3$로 처리하는 것은 taurine 강화에 도움이 되지 않았다.

• 한국수산과학회지
• /
• 제33권1호
• /
• pp.51-54
• /
• 2000

오징어 가공 폐액 중에는 기능성 물질로 분류되고 있는 taurine이 다량 함유되어 있다는 사실이 밝혀졌기에 고부가가치 물질로서의 이용을 위한 기초 자료의 확보를 위해 본 연구가 시도되었다. 오징어 가공공장에서 각 공정별로 시료를 취하여 유리 아미노산과 taurine의 함량을 측정하고, 탈피액이나 자숙액 중의 taurine 함량을 확인하였다. 그 결과 원료, 탈피 및 자숙 오징어의 경우 proline이 $800{\~}997mg/100g$으로 가장 높은 함량을 나타내었고, 다음으로 taurine이 $730{\~}820mg/100g$으로 높았다. 자숙 오징어는 아미노산의 손실이 일어나 원료에 비해 $60{\%}$ 정도의 유리아미노산이 감소한 것으로 나타났으며, taurine의 함량도 다른 아미노산과 마찬가지로 크게 감소한 것으로 확인되었다. 조미 오징어 제품에서의 taurine 함량은 큰 변화가 없었는데, 이는 자국 전처리 과정 중에 taurine이 크게 감소한 후 조미 및 구이 공정에서는 큰 변화가 없는 것으로 판단되었다. 한편, 탈피액 및 자숙액 중의 유리 아미노산 함량은 각각 639.1 mg/100ml, 470.7ml100ml이었고, 이중 taurine 함량이 각각 144.9mg/100ml, 117.9mg/100ml로 유리아미노산의 약 $30{\%}$를 차지하였다. 이상의 결과로 오징어 가공공정 중의 탈피 및 자숙 과정 중에 유출되는 taurine을 효율적으로 회수할 수 있는 방법이 개발된다면 가공폐수의 처리는 물론이고 taurine 산업적 생산도 가능할 것으로 판단되었다.

• 동아시아식생활학회지
• /
• 제21권2호
• /
• pp.257-262
• /
• 2011

본 연구에서는 타우린 첨가가 김치 발효 과정중의 미생물학적 변화에 미치는 영향에 대하여 알아보았다. 대조군은 타우린을 첨가하지 않았으며, Taurine I, II 및 III군은 각각 1, 2 및 4%의 타우린(w/w, 배추 기준)을 첨가하여 제조하였다. 모든 군의 pH는 발효가 진행됨에 따라 점차적으로 저하되다가 pH 4.0 정도에 도달한 후부터는 거의 변화가 없었다. 총균수는 김치의 숙성이 진행됨에 따라 초기에 급속히 증가한 후 완만한 증가를 하였다. 최대 총균수는 대조군이 발효 5일째 가장 많았고, Taurine I이 9일째, Taurine II가 발효 23일째, Taurine III가 발효 18일째의 순으로 나타났다. 대조군의 적숙기에서의 총 젖산균 수는 발효 9일째 $1.3{\times}10^9$ CFU/mL였으며, 타우린 김치의 총젖산균 수는 적숙기 8~18일 사이에 가장 많게 나타났으며($8.9{\times}10^8{\sim}1.3{\times}10^9$ CFU/mL), 타우린의 첨가는 김치 발효 중 젖산균의 생육 활성을 지연시킴을 알 수 있었다. 특히 타우린 첨가군의 Leuconostoc속 젖산균 생육 활성이 지연되어 김치의 숙성 기간이 대조군에 비해 연장되는 것으로 사료된다.

• 동아시아식생활학회지
• /
• 제14권1호
• /
• pp.20-26
• /
• 2004

The purpose of this study was to investigate dietary taurine intakes, plasma taurine levels and urinary taurine excretions of women in Seoul(Kangbuk-ku) and Kyunggi(Yeoju) area, Korea. Seventy married women aged 39.7$\pm$8.9 have volunteered for this study: 36 from Seoul area and 34 from Kyunggi area. Diet samples were collected from the participants and the samples included three meals (breakfast, lunch and supper), snacks, drinks and whatever the participants had eaten for 24 hours. The plasma was obtained by allowing a 5 $m\ell$ fasting blood sample to be in a heparinized tube for 30 min and centrifuging it at 11,000${\times}$g for 20 min. The collected diets were blended, centrifuged and deproteinized. Taurine levels in the diet and plasma were determined as the dabsyl derivative using HPLC with Rf-detector. The intake of taurine ranged from 6.8 to 837.8 mg/day and its mean value was l45.5$\pm$164.0 mg/day (mean$\pm$SD). The 90th, 50th and 10th percentile values of the taurine intake were 280.0, 94.3 and 26.8 mg/day, respectively. There was a significant difference between two groups: 202.0$\pm$204.9 for Seoul area and 85.5$\pm$67.2 mg/day for Kyunggi area(p<0.00l). The taurine level in plasma ranged from 42.1 to 201.9 $\mu$mol/L and its mean value was 74.9$\pm$22.8 $\mu$mol/L. The 90th, 50th and 10th percentile values of the plasma taurine were 101.1, 70.7 and 54.6 $\mu$mol/L, respectively. There was no significant difference between Seoul area and Kyunggi area in plasma taurine level.